ID   WAe009-A-18
AC   CVCL_ZC37
SY   H9TLR7HET; KSCBe010-A-18
DR   hPSCreg; WAe009-A-18
DR   SKIP; SKIP005733
DR   Wikidata; Q98134735
RX   PubMed=32268246;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 15631; TLR7 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=32268246
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 12.3,13
ST   D21S11: 30
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   Penta D: 9,13
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 7
//
RX   PubMed=32268246; DOI=10.1016/j.scr.2020.101735;
RA   Seo H.-H., Han H.-W., Kim J.-H.;
RT   "Generation of a TLR7 heterozygous knockout line (WAe009-A-18) from
RT   human embryonic stem cells using CRISPR/Cas9.";
RL   Stem Cell Res. 45:101735-101735(2020).
//